Animal Models

In response to a commentary by Frederick K. Goodwin and Adrian R. Morrison ("In Animal Rights Debate, The Only Valid Moderates Are Researchers," The Scientist, Sept. 6, 1993, page 12), Neal D. Barnard states that he has been misinterpreted in regard to his statements about animal experimentation (Letters, The Scientist, Nov. 15, 1993, page 12). No one has been misinterpreting Barnard's stand on animal experimentation, as his positi

Written byGabor Kaley
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In response to a commentary by Frederick K. Goodwin and Adrian R. Morrison ("In Animal Rights Debate, The Only Valid Moderates Are Researchers," The Scientist, Sept. 6, 1993, page 12), Neal D. Barnard states that he has been misinterpreted in regard to his statements about animal experimentation (Letters, The Scientist, Nov. 15, 1993, page 12).

No one has been misinterpreting Barnard's stand on animal experimentation, as his position is and has been crystal clear. As president of the egregiously misnamed Physicians Committee for Responsible Medicine, he wants to stop all use of animals in research and education.

He does not consider that research performed on animals is useful in promoting human and animal health and mistakenly calls for replacing all animal models with nonanimal models in testing and experimentation.

When thalidomide was approved in Europe for human use without extensive testing in animals, the tragic effects of the drug on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies